Expected use of approximately $25 million in first quarter of 2025 intended to preserve approximately 200,000 ADSs held as ...

Global net sales of EPKINLY/TEPKINLY were USD 281 million in 2024. Net product sales in the U.S. and Japan by Genmab were DKK 1,743 million in 2024 compared to DKK 421 million in 2023. EPKINLY was ...

Sampo plc, stock exchange release, 12 February 2025 at 8:30 am EET New Sampo shares issued in the share split registered with the Finnish Trade Register Sampo plc announced on 5 February 2025 the ...

Company Announcement COPENHAGEN, Denmark; February 12, 2025 - Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024 ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Genmab A/S (Nasdaq: GMAB) announced today that it has filed its Annual Report for the financial year 2024 on Form 20-F with the U.S. Securities and Exchange Commission (SEC), incorporating by ...

Finnish financial company Sampo plc has successfully registered the new shares issued in its previously announced share split with the Finnish Trade Register. This development follows the company's ...

COPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company valued at $7.15 billion, has initiated a share ...

Company announcement for ROCKWOOL A/S Release no. 08 – 2025 to Nasdaq Copenhagen        12 February 2025 ROCKWOOL A/S – transactions in connection with share buy-back programme As mentioned in ...

EDEN's concentrated portfolio, with the top 5 holdings making up 42% of the fund, allows for easier tracking and potential ...

Total volumes in January 2025 of 3.3m lane metres were 1.4% below 2024.North Sea volumes were below 2024 due to mainly lower automotive volumes. Mediterranean volumes were below 2024 following ...